Cargando…
Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017
BACKGROUND: Plasmodium vivax is the predominant Plasmodium species in Afghanistan. National guidelines recommend the combination of chloroquine and primaquine (CQ-PQ) for radical treatment of P. vivax malaria. Artesunate in combination with the antifolates sulfadoxine-pyrimethamine (SP) has been fir...
Autores principales: | Rakmark, Kasama, Awab, Ghulam R., Duanguppama, Jureeporn, Boonyuen, Usa, Dondorp, Arjen M., Imwong, Mallika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362531/ https://www.ncbi.nlm.nih.gov/pubmed/32664924 http://dx.doi.org/10.1186/s12936-020-03319-0 |
Ejemplares similares
-
Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan
por: Awab, Ghulam R, et al.
Publicado: (2013) -
Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
por: Awab, Ghulam Rahim, et al.
Publicado: (2010) -
Polymorphisms in Pvkelch12 and gene amplification of Pvplasmepsin4 in Plasmodium vivax from Thailand, Lao PDR and Cambodia
por: Duanguppama, Jureeporn, et al.
Publicado: (2019) -
Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016
por: Sugaram, Rungniran, et al.
Publicado: (2020) -
Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
por: Awab, Ghulam Rahim, et al.
Publicado: (2016)